Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Chavez Tapia, Norberto C ^a,b,c   Rosso, Natalia ^a   Tiribelli, Claudio ^a  

^a Fondazione Italiana Fegato Centro Studi Fegato   (Italy)

^b Centro Studi Fegato   (Italy)

^c LIVER RESEARCH UNIT   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BOVINE SERUM ALBUMIN; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; FAT DROPLET; FATTY ACID; INTERLEUKIN 6; INTERLEUKIN 8; OLEIC ACID; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN B; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

APOPTOSIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOTOXICITY; FAT CONTENT; FLOW CYTOMETRY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LIPID STORAGE; NONALCOHOLIC FATTY LIVER; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; UPREGULATION; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; FATTY LIVER; IN VITRO STUDY; LIPID METABOLISM; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIVER NEOPLASMS; MODELS, BIOLOGICAL; OLEIC ACID; OXIDATIVE STRESS; PALMITIC ACID; REACTIVE OXYGEN SPECIES;

EID: 84857539784     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-20     Document Type: Article

References (37)

1. Bellentani S, Bedogni G, Tiribelli C. Liver and heart: a new link?. J Hepatol 2008, 49(2):300-302. 10.1016/j.jhep.2008.05.003, 18554746.
2. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008, 88(1):125-172. 10.1152/physrev.00013.2007, 2888531, 18195085.
3. Nieto N, Friedman SL, Cederbaum AI. Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. J Biol Chem 2002, 277(12):9853-9864. 10.1074/jbc.M110506200, 11782477.
4. Basu A, Saito K, Meyer K, Ray RB, Friedman SL, Chang YH, Ray R. Stellate cell apoptosis by a soluble mediator from immortalized human hepatocytes. Apoptosis 2006, 11(8):1391-1400. 10.1007/s10495-006-8312-z, 16830231.
5. Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, Foti M. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol 2009, 50(6):1132-1141. 10.1016/j.jhep.2009.01.027, 19398230.
6. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65(1-2):55-63. 10.1016/0022-1759(83)90303-4, 6606682.
7. McMillian MK, Grant ER, Zhong Z, Parker JB, Li L, Zivin RA, Burczynski ME, Johnson MD. Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. In Vitr Mol Toxicol 2001, 14(3):177-190. 10.1089/109793301753407948, 11846991.
8. Greenspan P, Fowler SD. Spectrofluorometric studies of the lipid probe, nile red. J Lipid Res 1985, 26(7):781-789.
9. Sottile V, Seuwen K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 2000, 475(3):201-204. 10.1016/S0014-5793(00)01655-0, 10869556.
10. O'Connor JE, Martinez A, Castell JV, Gomez-Lechon MJ. Multiparametric characterization by flow cytometry of flow-sorted subpopulations of a human hepatoma cell line useful for drug research. Cytometry A 2005, 63(1):48-58.
11. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150(1):76-85. 10.1016/0003-2697(85)90442-7, 3843705.
12. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 1994, 55(2):253-258.
13. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005, 41(6):1211-1219. 10.1002/hep.20720, 15915465.
14. Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 1997, 272(35):22173-22181. 10.1074/jbc.272.35.22173, 9268362.
15. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 2008, 14(2):72-81. 10.1016/j.molmed.2007.12.003, 18218340.
16. Matsuguchi T, Okamura S, Kawasaki C, Niho Y. Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein. Cancer Res 1990, 50(23):7457-7459.
17. George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003, 39(5):756-764. 10.1016/S0168-8278(03)00376-3, 14568258.
18. Gressner OA, Lahme B, Demirci I, Gressner AM, Weiskirchen R. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 2007, 47(5):699-710. 10.1016/j.jhep.2007.05.015, 17629588.
19. Garcia MC, Amankwa-Sakyi M, Flynn TJ. Cellular glutathione in fatty liver in vitro models. Toxicol In Vitro 2011, 25(7):1501-1506. 10.1016/j.tiv.2011.05.011, 21620948.
20. Gribilas G, Zarros A, Zira A, Giaginis C, Tsourouflis G, Liapi C, Spiliopoulou C, Theocharis SE. Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat. Dig Dis Sci 2009, 54(11):2367-2376. 10.1007/s10620-008-0623-1, 19082714.
21. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Laboratory Investigation A Journal Of Technical Methods And Pathology 2003, 83(5):655-663.
22. Ibrahim SH, Kohli R, Gores GJ. Mechanisms of lipotoxicity in NAFLD and clinical implications. J Pediatr Gastroenterol Nutr 2011, 53(2):131-140.
23. Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta 2010, 1801(3):299-310.
24. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 2004, 106(6):635-643.
25. Brodersen R, Andersen S, Vorum H, Nielsen SU, Pedersen AO. Multiple fatty acid binding to albumin in human blood plasma. Eur J Biochem 1990, 189(2):343-349. 10.1111/j.1432-1033.1990.tb15495.x, 2338079.
26. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain CJ. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 2007, 46(3):823-830. 10.1002/hep.21752, 17680645.
27. Chavez-Tapia NC, Rosso N, Tiribelli C. In vitro models for the study of non-alcoholic fatty liver disease. Curr Med Chem 2011, 18(7):1079-1084. 10.2174/092986711794940842, 21254970.
28. Nguyen TH, Mai G, Villiger P, Oberholzer J, Salmon P, Morel P, Buhler L, Trono D. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes. J Hepatol 2005, 43(6):1031-1037. 10.1016/j.jhep.2005.05.036, 16169114.
29. Chavez-Tapia N, Rosso C, Tiribelli C. Increased expression of IL-6 and IL-8 mrna in human immortalized hepatocytes after fat overload. J Hepatol 2009, 50(S1):S2546.
30. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 2008, 103(6):1372-1379. 10.1111/j.1572-0241.2007.01774.x, 18510618.
31. Prabhakar U, Conway TM, Murdock P, Mooney JL, Clark S, Hedge P, Bond BC, Jazwinska EC, Barnes MR, Tobin F, et al. Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol 2005, 24(7):410-431. 10.1089/dna.2005.24.410, 16008510.
32. Zhan SS, Jiang JX, Wu J, Halsted C, Friedman SL, Zern MA, Torok NJ. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 2006, 43(3):435-443. 10.1002/hep.21093, 16496318.
33. Bechmann LP, Zahn D, Gieseler RK, Fingas CD, Marquitan G, Jochum C, Gerken G, Friedman SL, Canbay A. Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells. Hepatol Res 2009, 39(6):601-608. 10.1111/j.1872-034X.2008.00485.x, 2893585, 19207580.
34. Canbay A, Seydel S, Beilfuss A, Kahraman A, Aksoy K, Gerken G, Akkiz H. Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2. Turk J Gastroenterol 2011, 22(4):400-407.
35. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982, 42(9):3858-3863.
36. Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gann 1984, 75(2):151-158.
37. March S, Hui EE, Underhill GH, Khetani S, Bhatia SN. Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro. Hepatology 2009, 50(3):920-928. 10.1002/hep.23085, 2890242, 19585615.